Potential role of IL-17 blocking agents in the treatment of severe COVID-19?

被引：40

作者：

Bulat, Vedrana ^{[1
]}

Situm, Mirna ^{[1
]}

Azdajic, Marija Delas ^{[1
]}

Likic, Robert ^{[2
,3
]}

机构：

[1] Univ Hosp Ctr Sestre Milosrdnice, Dept Dermatol & Venereol, Zagreb, Croatia

[2] Univ Zagreb, Sch Med, Zagreb, Croatia

[3] Univ Hosp Ctr Zagreb, Dept Internal Med, Div Clin Pharmacol & Therapeut, Zagreb, Croatia

来源：

关键词：

brodalumab; COVID-19; IL-17 blocking agents; ixekizumab; SARS-CoV-2; secukinumab; IMMUNOGENICITY; SECUKINUMAB;

D O I：

10.1111/bcp.14437

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1578 / 1581

页数：4